MONDAY, March 24, 2025 (HealthDay News) -- Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer diagnosis, according to a study ...

A standard diagnostic test for ovarian cancer is less effective in detecting the disease among Black and Native American ...

The blood test for CA-125, a commonly used marker for ovarian cancer, was never elevated for her, even when she was diagnosed with ovarian cancer at 38. "All three times that I was diagnosed with ...

The new study, supported by grants from the National Cancer Institute and published Thursday in JAMA Network Open, looked at a test called CA-125. The test measures a tumor marker in the blood ...

The measurement of serum CA-125 antigen is a standard procedure in the management of patients with advanced ovarian cancer. A study by Markman et al. showed that decreased concentration of serum ...

A recent retrospective analysis by Low and colleagues compared the use of laparotomy, MRI, and serum cancer antigen-125 (CA-125) levels for the detection of residual tumor in women treated for ...

About The Study: In this cohort study of patients with ovarian cancer, American Indian and Black patients were 23% less likely to have an elevated cancer antigen (CA)-125 level at diagnosis.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The cancer antigen (CA)-125 test may miss ovarian cancer in some Black and Native American patients, delaying their ...

The new study, supported by grants from the National Cancer Institute and published Thursday in JAMA Network Open, looked at a test called CA-125. The test measures a tumor marker in the blood ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It's the latest example of medical tests that contribute to ...